These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 34315958)

  • 41. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Racial and Ethnic Disparities in Heart and Cerebrovascular Disease Deaths During the COVID-19 Pandemic in the United States.
    Wadhera RK; Figueroa JF; Rodriguez F; Liu M; Tian W; Kazi DS; Song Y; Yeh RW; Joynt Maddox KE
    Circulation; 2021 Jun; 143(24):2346-2354. PubMed ID: 34000814
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Remote continuous glucose monitoring during the COVID-19 pandemic in quarantined hospitalized patients in Denmark: A structured summary of a study protocol for a randomized controlled trial.
    Klarskov CK; Lindegaard B; Pedersen-Bjergaard U; Kristensen PL
    Trials; 2020 Nov; 21(1):968. PubMed ID: 33239100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of shielding during the COVID-19 pandemic on mental health: evidence from the English Longitudinal Study of Ageing.
    Di Gessa G; Price D
    Br J Psychiatry; 2022 Oct; 221(4):637-643. PubMed ID: 35369895
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anticoagulants for people hospitalised with COVID-19.
    Flumignan RL; Civile VT; Tinôco JDS; Pascoal PI; Areias LL; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013739. PubMed ID: 35244208
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The 5% of the Population at High Risk for Severe COVID-19 Infection Is Identifiable and Needs to Be Taken Into Account When Reopening the Economy.
    Preskorn SH
    J Psychiatr Pract; 2020 May; 26(3):219-227. PubMed ID: 32421292
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A model for COVID-19 with isolation, quarantine and testing as control measures.
    Aronna MS; Guglielmi R; Moschen LM
    Epidemics; 2021 Mar; 34():100437. PubMed ID: 33540378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Piechotta V; Iannizzi C; Chai KL; Valk SJ; Kimber C; Dorando E; Monsef I; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013600. PubMed ID: 34013969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource.
    Wood A; Denholm R; Hollings S; Cooper J; Ip S; Walker V; Denaxas S; Akbari A; Banerjee A; Whiteley W; Lai A; Sterne J; Sudlow C;
    BMJ; 2021 Apr; 373():n826. PubMed ID: 33827854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Digital contact tracing technologies in epidemics: a rapid review.
    Anglemyer A; Moore TH; Parker L; Chambers T; Grady A; Chiu K; Parry M; Wilczynska M; Flemyng E; Bero L
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013699. PubMed ID: 33502000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Race and Ethnicity and Sex Variation in COVID-19 Mortality Risks Among Adults Experiencing Homelessness in Los Angeles County, California.
    Porter NAC; Brosnan HK; Chang AH; Henwood BF; Kuhn R
    JAMA Netw Open; 2022 Dec; 5(12):e2245263. PubMed ID: 36472872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Persistent Somatic Symptom Burden and Sleep Disturbance in Patients with COVID-19 During Hospitalization and After Discharge: A Prospective Cohort Study.
    Huang S; Zhuang W; Wang D; Zha L; Xu X; Li X; Shi Q; Wang XS; Qiao G
    Med Sci Monit; 2021 Apr; 27():e930447. PubMed ID: 33854028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcome Disparities Among Men and Women With COVID-19: An Analysis of the New York City Population Cohort.
    Punjani N; Ha A; Caputo J; Wang V; Wiechmann L; Chiasson MA; Li P; Hotaling J; Walsh T; Alukal J
    J Drugs Dermatol; 2020 Oct; 19(10):960-967. PubMed ID: 33026775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The association between various indicators of hospital capacity, age category, and the number of screening tests performed with case fatality rate and recovery rate during the COVID-19 disease pandemic.
    Khafaie MA; Malehi AS; Rahim F
    J Prev Med Hyg; 2021 Jun; 62(2):E261-E269. PubMed ID: 34604564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prophylactic anticoagulants for non-hospitalised people with COVID-19.
    Santos BC; Flumignan RL; Civile VT; Atallah ÁN; Nakano LC
    Cochrane Database Syst Rev; 2023 Aug; 8(8):CD015102. PubMed ID: 37591523
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibiotics for the treatment of COVID-19.
    Popp M; Stegemann M; Riemer M; Metzendorf MI; Romero CS; Mikolajewska A; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD015025. PubMed ID: 34679203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preparedness for self-isolation or quarantine and lockdown in South Africa: results from a rapid online survey.
    Sifunda S; Mokhele T; Manyaapelo T; Dukhi N; Sewpaul R; Parker WA; Parker S; Naidoo I; Jooste S; Ramlagan S; Gaida R; Mabaso M; Zuma K; Reddy P
    BMC Public Health; 2021 Mar; 21(1):580. PubMed ID: 33757461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vaccine coverage and effectiveness against laboratory-confirmed symptomatic and severe Covid-19 in indigenous people in Brazil: a cohort study.
    Pescarini JM; Cardoso AM; Santos RV; Scaff PF; Paixao ES; Ranzani OT; Cerqueira-Silva T; Boaventura VS; Bertoldo-Junior J; de Oliveira VA; Werneck GL; Barreto ML; Barral-Netto M
    BMC Public Health; 2023 Jun; 23(1):1267. PubMed ID: 37386490
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
    Struyf T; Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Leeflang MM; Spijker R; Hooft L; Emperador D; Domen J; Tans A; Janssens S; Wickramasinghe D; Lannoy V; Horn SRA; Van den Bruel A;
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013665. PubMed ID: 35593186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.